Wellington Biomedical Innovation Master Investors (Cayman) II L.P. 13D and 13G filings for MBX Biosciences, Inc. Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-09-20 10:13 am Purchase | 2024-09-13 | 13G | MBX Biosciences, Inc. Common Stock MBX | Wellington Biomedical Innovation Master Investors (Cayman) II L.P. | 1,790,122 5.620% | 1,790,122 (New Position) | Filing |